Rockefeller Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $713K | Buy |
84,165
+5,000
| +6% | +$42.4K | ﹤0.01% | 1443 |
|
2025
Q1 | $636K | Sell |
79,165
-35
| -0% | -$281 | ﹤0.01% | 1407 |
|
2024
Q4 | $711K | Buy |
79,200
+35
| +0% | +$314 | ﹤0.01% | 1365 |
|
2024
Q3 | $580K | Sell |
79,165
-159
| -0.2% | -$1.17K | ﹤0.01% | 1390 |
|
2024
Q2 | $453K | Buy |
79,324
+159
| +0.2% | +$908 | ﹤0.01% | 1469 |
|
2024
Q1 | $397K | Sell |
79,165
-2,005
| -2% | -$10K | ﹤0.01% | 1531 |
|
2023
Q4 | $730K | Buy |
81,170
+5
| +0% | +$45 | ﹤0.01% | 1247 |
|
2023
Q3 | $631K | Hold |
81,165
| – | – | ﹤0.01% | 1237 |
|
2023
Q2 | $786K | Hold |
81,165
| – | – | ﹤0.01% | 1176 |
|
2023
Q1 | $889K | Buy |
81,165
+2,000
| +3% | +$21.9K | ﹤0.01% | 1123 |
|
2022
Q4 | $341K | Hold |
79,165
| – | – | ﹤0.01% | 1423 |
|
2022
Q3 | $595K | Hold |
79,165
| – | – | ﹤0.01% | 1204 |
|
2022
Q2 | $795K | Hold |
79,165
| – | – | ﹤0.01% | 1073 |
|
2022
Q1 | $980K | Hold |
79,165
| – | – | ﹤0.01% | 1061 |
|
2021
Q4 | $1.81M | Sell |
79,165
-14,420
| -15% | -$330K | 0.01% | 833 |
|
2021
Q3 | $2.07M | Buy |
93,585
+500
| +0.5% | +$11.1K | 0.01% | 736 |
|
2021
Q2 | $1.21M | Hold |
93,085
| – | – | 0.01% | 864 |
|
2021
Q1 | $1.21M | Hold |
93,085
| – | – | 0.01% | 726 |
|
2020
Q4 | $1.29M | Sell |
93,085
-1,000
| -1% | -$13.8K | 0.01% | 631 |
|
2020
Q3 | $1.39M | Hold |
94,085
| – | – | 0.01% | 517 |
|
2020
Q2 | $1.53M | Buy |
94,085
+1,000
| +1% | +$16.3K | 0.02% | 453 |
|
2020
Q1 | $1.35M | Hold |
93,085
| – | – | 0.02% | 409 |
|
2019
Q4 | $1.89M | Hold |
93,085
| – | – | 0.02% | 357 |
|
2019
Q3 | $497K | Buy |
93,085
+1,500
| +2% | +$8.01K | 0.01% | 492 |
|
2019
Q2 | $603K | Hold |
91,585
| – | – | 0.01% | 416 |
|
2019
Q1 | $595K | Hold |
91,585
| – | – | 0.01% | 456 |
|
2018
Q4 | $625K | Buy |
+91,585
| New | +$625K | 0.01% | 294 |
|